We are live on ! Find out more
FPF

FNY Partners Fund Portfolio holdings

AUM $185M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+14.16%
1 Year Est. Return
+32.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$588M
AUM Growth
+$175M
Cap. Flow
+$118M
Cap. Flow %
20.16%
Top 10 Hldgs %
54.34%
Holding
835
New
294
Increased
101
Reduced
91
Closed
281

Sector Composition

Rank Sector Weight
1 Healthcare 26.11%
2 Technology 14.68%
3 Communication Services 11.2%
4 Financials 9.54%
5 Consumer Staples 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISEE
701
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-3,000
Closed -$7K
NYMX
702
DELISTED
Nymox Pharmaceutical Corp
NYMX
-8,000
Closed -$35K
BSMX
703
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
-1,000
Closed -$9K
CLVS
704
DELISTED
Clovis Oncology, Inc.
CLVS
-4,000
Closed -$317K
CLR
705
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-48
Closed -$1K
CLR
706
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-2,000
Closed -$64K
TWTR
707
CALL
DELISTED
Twitter, Inc.
TWTR
-100
Closed -$1K
HSTO
708
DELISTED
Histogen Inc. Common Stock
HSTO
-99
Closed -$114K
ALXN
709
DELISTED
Alexion Pharmaceuticals
ALXN
-251
Closed -$30K
MDLY
710
DELISTED
Medley Management Inc
MDLY
-250
Closed -$16K
IPHI
711
DELISTED
INPHI CORPORATION
IPHI
-5,550
Closed -$190K
FIT
712
DELISTED
Fitbit, Inc. Class A common stock
FIT
$0 ﹤0.01%
+100
New +$582
HDS
713
DELISTED
HD Supply Holdings, Inc.
HDS
-500
Closed -$15K
ENT
714
CALL
DELISTED
Global Eagle Entertainment Inc.
ENT
-12
Closed -$1K
PTLA
715
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-20
Closed -$1K
RTN
716
DELISTED
Raytheon Company
RTN
-500
Closed -$80K
AKS
717
DELISTED
AK Steel Holding Corp
AKS
-500
Closed -$3K
INXN
718
DELISTED
Interxion Holding N.V.
INXN
-700
Closed -$32K
CPL
719
DELISTED
CPFL Energia S.A.
CPL
-162
Closed -$2K
MDCO
720
CALL
DELISTED
Medicines Co
MDCO
-100
Closed -$3K
MDCO
721
DELISTED
Medicines Co
MDCO
-6,006
Closed -$228K
BKJ
722
DELISTED
Bancorp of New Jersey, Inc.
BKJ
-1,103
Closed -$15K
CRZO
723
DELISTED
Carrizo Oil & Gas Inc
CRZO
-1,000
Closed -$17K
VIAB
724
PUT
DELISTED
Viacom Inc. Class B
VIAB
-50
Closed -$1K
NVLN
725
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
-5,917
Closed -$54K

Similar funds

FNY Partners Fund's Q3 2017 Portfolio in Review

As of Q3 2017, FNY Partners Fund held 835 positions worth $588M, up 42% from $413M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

FNY Partners Fund deployed $118M of net new capital in Q3 2017, opening 294 new positions and adding to 101 existing holdings. Its largest new stake was Kite Pharma, Inc.: 379,510 shares worth $68.2M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 10% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Altaba Inc, an estimated $24.9M trimmed.

  • FNY Partners Fund's largest Q3 2017 buy was Kite Pharma, Inc.: 379,510 shares worth $68.2M.
  • FNY Partners Fund added most to Time Warner Inc in Q3 2017, an estimated $36.4M increase.
  • FNY Partners Fund's biggest Q3 2017 reduction was Altaba Inc, cutting an estimated $24.9M.
  • FNY Partners Fund fully exited Allied World Assurance Co Hld Lt in Q3 2017, selling an estimated $54.6M.
  • FNY Partners Fund's ten largest holdings make up 54% of its $588M portfolio in Q3 2017.
  • FNY Partners Fund opened 294 new positions and closed 281 in Q3 2017.
  • FNY Partners Fund's portfolio value rose 42% quarter-over-quarter to $588M.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.